期刊
ARCHIVES OF MICROBIOLOGY
卷 202, 期 3, 页码 473-482出版社
SPRINGER
DOI: 10.1007/s00203-019-01764-3
关键词
Bacteroides fragilis; Auranofin; Antibiofilm; Antibacterial; ompA gene; bmeB3 gene
类别
资金
- Soonchunhyang University [20190911]
- Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2017R1D1A1B03032960]
The aim of this study is to evaluate the antibiofilm and antibacterial effects of auranofin against WT-ETBF, rETBF, WT-NTBF and clinically isolated Bacteroides fragilis strains. The minimum inhibitory concentration and biofilm inhibitory concentration of 0.25 mu g/ml for auranofin against B. fragilis were determined, and the biofilm eradication concentration was 1 mu g/ml. At an auranofin concentration of 0.5 mu g/ml, little cellular metabolic activity was found. Confocal laser scanning microcopy results confirmed the inhibition of biofilm by auranofin. The effects of auranofin on the outer membrane protein (ompA) gene and the RND-type efflux pump (bmeB3) gene were investigated using quantitative real-time polymerase chain reaction (qRT-PCR). The qRT-PCR results showed that treatment with auranofin significantly reduced the gene expression compared to controls without auranofin. These data indicate the applicability of auranofin as a repurposed drug due to its inhibitory effect against biofilm formation of B. fragilis. Therefore, our study demonstrates that auranofin, already approved for human use, is a promising drug that has strong antibiofilm and antibacterial activity against B. fragilis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据